These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 83728)

  • 1. Detection of non-HLA antibodies in bone marrow transplant recipients.
    Opelz G; Walker J; Gale RP
    Transplant Proc; 1978 Dec; 10(4):963-4. PubMed ID: 83728
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-HLA lymphocytotoxic antibodies during GVHD after bone marrow transplantation (BMT).
    Gluckman E; Andersen E; Lepage V; Dausset J
    Transplant Proc; 1977 Mar; 9(1):761-3. PubMed ID: 17200
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunobiology of transplant rejection.
    Häyry P
    Ann Clin Res; 1981; 13(4-5):172-98. PubMed ID: 7039479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology of bone marrow grafts].
    Dreyfus F
    Ann Med Interne (Paris); 1986; 137(8):617-20. PubMed ID: 3551717
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA and bone marrow transplantation.
    Bach FH
    Prog Clin Biol Res; 1984; 149():257-70. PubMed ID: 6204340
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of selective donor T-cell depletion on the graft-versus-leukemia reaction in allogeneic marrow transplantation.
    OKunewick J; Kociban D; Machen L; Buffo M
    Transplant Proc; 1992 Dec; 24(6):2998-9. PubMed ID: 1361270
    [No Abstract]   [Full Text] [Related]  

  • 9. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation.
    van Rood JJ; van Leeuwen A
    Transplant Proc; 1976 Sep; 8(3):429-36. PubMed ID: 62433
    [No Abstract]   [Full Text] [Related]  

  • 10. The human histocompatibility complex: a review for the hematologist.
    Miller WV
    Prog Hematol; 1977; 10():173-91. PubMed ID: 337359
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunorestoration.
    Good RA; Kapoor N
    Symp Fundam Cancer Res; 1986; 38():269-74. PubMed ID: 3529277
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone marrow transplantation and immunologic reconstitution].
    Piazzon I; Dosne Pasqualini C
    Medicina (B Aires); 1981; 41(2):233-43. PubMed ID: 7024717
    [No Abstract]   [Full Text] [Related]  

  • 14. Major histocompatibility complex influences the development of acute graft-versus-host disease in MHC-matched adult allogeneic bone marrow transplantation.
    Smyth LA; Herrmann RP; Christiansen FT; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1276-8. PubMed ID: 8442111
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation across major histocompatibility barriers in rabbits. I. A positive role for graft-versus-host reactivity in engraftment.
    Adler LT; Annaratone LJ; LeBeau MM
    Bone Marrow Transplant; 1990 Jan; 5(1):51-6. PubMed ID: 2297590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different biology and pathology of minor alloantigen-specific cytotoxic and proliferative T cells.
    van Els C; Bakker A; van Rood J; Goulmy E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):429-30. PubMed ID: 1990577
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 19. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.